Alprostadil Injectable Recalled for Lack of Sterility Assurance
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling Alprostadil 40 mcg/mL injectable vials due to lack of assurance of sterility. The recall affects the U.S. including Washington, D.C. and Puerto Rico.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The FDA classified this as a Class II recall. The hazard is lack of sterility assurance for an injectable drug, which represents a risk of serious harm (infection, sepsis) to patients if contaminated product were administered. No illnesses or injuries are reported in the source text, but the risk is inherent to the defect.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy, located at 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247, is recalling Alprostadil 40 mcg/mL Injectable (prescription only) due to lack of assurance of sterility.
The recalled product consists of 4 vials distributed throughout the United States, including Washington, D.C. and Puerto Rico. The affected lot numbers and beyond-use dates are: Lot 06242021:37 with BUD 10/22/2021; Lot 08132021:74 with BUD 12/11/2021; and Lot 07132021:94 with BUD 10/23/2021.
Patients currently using this product should consult their healthcare provider or pharmacist immediately. Consumers who have this medication should not use it and should return it to their pharmacy or the recalling firm.
The recalled product
- Product
- ALPROSTADIL 40MCG/ML INJ 40MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Hazard
- sterility-assurance
- injectable-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot: 06242021:37 BUD: 10/22/2021
- 08132021:74 BUD: 12/11/2021
- 07132021:94 BUD:10/23/2021
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27